Peer Review History

Original SubmissionJanuary 7, 2020
Decision Letter - Ortrun Mittelsten Scheid, Editor, Gregory P. Copenhaver, Editor

* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. *

Dear Dr Ulm,

Thank you very much for submitting your Research Article entitled 'UVR8-mediated inhibition of shade avoidance involves HFR1 stabilization in Arabidopsis' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some aspects of the manuscript that should be improved.

As you will see from the detailed comments of the reviewers, they consider the findings important and appreciate the well-written manuscript, adding a connecting element to a plausible model how UV exposure overcomes the shade avoidance response. Both reviewers suggest minor improvements that indeed could make the paper even stronger, but these should be easy to incorporate and address.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Ortrun Mittelsten Scheid

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Under FR-rich light, as under a canopy, plants exhibit a shade avoidance response (SAS) leading to enhanced elongation growth. The UV-B receptor UVR8 represses the shade avoidance response under UV-B. This mechanism might lead to a rapid stop in the shade avoidance response when plants grow out of the canopy into the direct sunlight. The molecular mechanisms leading to UV-B-induced suppression of the SAS are poorly understood and currently of great interest to plant biologists.

In this manuscript, the authors demonstrate the important function of the transcription factor HFR1 in UV-B-induced suppression of the SAS. HFR1 is an important repressor of the SAS. The authors show that UV-B enhances the activity of HFR1 by stabilizing the HFR1 protein. They further show that HFR1 is indeed necessary for the UV-B-induced suppression of a subset of SAS marker genes. Indeed, UV-B inhibits binding of PIF4 to the promoter of a subset of shade marker genes and this inhibition is to a large extent dependent on HFR1. Because UV-B induced PIF4 degradation is HFR1-independent, HFR1 activity on PIF4 is independent of the regulation of PIF4 stability.

This manuscript very conclusively uncovers the important role of HFR1 in UV-B signaling under shade conditions. The data therefore very nicely link the activities of UVR8, COP1, HFR1 and PIF4. Their results support the conclusions drawn by the authors. The manuscript is well written.

Major comments:

- the molecular phenotype of the hfr1 mutant in +FR+UV-B is very well analyzed and presented. I am wondering about the visible phenotype of an hfr1 mutant in +FR+UV-B in comparison to +FR? I.e. hypocotyl elongation.

Minor comments:

- please provide a statistical analysis of the ChIP data.

- it appears to me that Fig. 6C very nicely demonstrates that UV-B shows a much weaker inhibition of PIF4-binding to the PIL1 promoter in an hfr1 mutant than in the WT – despite no change in PIF4 protein levels in hfr1 vs. WT in +UV-B (Fig. 6A). In my view, this very nicely demonstrates that UV-B – via HFR1 – inhibits the DNA-binding activity of PIF4 – which is consistent with the known activity of HFR1 which heterodimerizes with PIFs. However, the authors do not really make this point in the results section. Is there a reason for that?

Reviewer #2: The present manuscript by Tavridou et al investigates the molecular details of UVB-mediated inhibition of shade avoidance syndrome (SAS). SAS is induced by low red:far-red (R:FR) light ratios indicating neighbouring plants in close proximity and is characterised by the induction of a well-defined gene set by the PIF4 and PIF5 transcription factors, eventually resulting in accelerated elongation. UVB, perceived by the UVR8 receptor, inhibits this response. The authors showed that UVB promotes the accumulation of the HFR1 transcription factor probably via the UVR8-mediated sequestration of the COP1 E3 ubq ligase, which targets HFR1 for degradation in the dark or in shade conditions. HFR1 forms inactive heterodimers with PIF4 and PIF5 transcription factors that attenuates SAS-related gene expression. They showed that PIL1, another transcription factor implicated in the regulation of SAS acts redundantly with HFR1 in this process. This newly identified molecular mechanism along with the previously described UVB-induced degradation of PIF4 and PIF5 have an important role in the termination of elongation once the plant has overgrown shade.

The experiments are well-planned and executed, providing convincing results. The text is focused, easy to read. The figures are informative and of good quality.

I have just a few minor comments and questions to this manuscript. Answers to the questions might be even incorporated in the Discussion.

1. Abstract, line 33: I would say ‘PIl1-mediated inhibition of PIF4 and PIF5 function’, to indicate that this regulation does not target the expression/level of PIFs.

2. I suggest to quantitate signals on all Western-blots (not only the one in Fig.6). Statistical analysis of these data would provide a robust support for the key statements/findings.

3. Fig.S4 seems to be not finalized yet: „devoid G” should be changed to „devoid G-box” (and explain this in the legends), and indicate HA-derived or mock immunoprecipitation in panel A as well.

4. Fig.2B demonstrates that a significant number of genes are induced by FR in the uvr8 mutant, but not in Col. How could the authors explain this if UVR8 was told to have function in UVB only?

5. Fig.2 deals with shade-induced genes. Did the authors identify shade-repressed genes in their RNA-seq assay? If yes, how was the repression affected by the UVB treatment?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Revision 1

Attachments
Attachment
Submitted filename: Tavridou_PLoSGenet_Response_to_Reviewers_Comments_2020.pdf
Decision Letter - Ortrun Mittelsten Scheid, Editor, Gregory P. Copenhaver, Editor

Dear Dr Ulm,

We are pleased to inform you that your manuscript entitled "UVR8-mediated inhibition of shade avoidance involves HFR1 stabilization in Arabidopsis" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Ortrun Mittelsten Scheid

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors addressed my comments satisfactorily.

Reviewer #2: The authors have addressed all of my concerns and I accept all of their responses to my specific questions. In my opinion, neither further experiments nor modifications to the text are required.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-00017R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Formally Accepted
Acceptance Letter - Ortrun Mittelsten Scheid, Editor, Gregory P. Copenhaver, Editor

PGENETICS-D-20-00017R1

UVR8-mediated inhibition of shade avoidance involves HFR1 stabilization in Arabidopsis

Dear Dr Ulm,

We are pleased to inform you that your manuscript entitled "UVR8-mediated inhibition of shade avoidance involves HFR1 stabilization in Arabidopsis" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Jason Norris

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .